
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18620372
[patent_doc_number] => 11753400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => D-amino acid oxidase inhibitors and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/757327
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 27108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757327 | D-amino acid oxidase inhibitors and therapeutic uses thereof | Oct 17, 2018 | Issued |
Array
(
[id] => 17697068
[patent_doc_number] => 11370778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases
[patent_app_type] => utility
[patent_app_number] => 16/756416
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24722
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 336
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756416 | Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases | Oct 16, 2018 | Issued |
Array
(
[id] => 16383307
[patent_doc_number] => 10808129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Methine dyes
[patent_app_type] => utility
[patent_app_number] => 16/155111
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7093
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155111 | Methine dyes | Oct 8, 2018 | Issued |
Array
(
[id] => 16383172
[patent_doc_number] => 10807994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Heterocyclic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/155841
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64476
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155841 | Heterocyclic compounds and uses thereof | Oct 8, 2018 | Issued |
Array
(
[id] => 14158691
[patent_doc_number] => 20190106448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => MANGANESE (III) CATALYZED C--H AMINATIONS
[patent_app_type] => utility
[patent_app_number] => 16/153178
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153178 | Manganese (III) catalyzed C--H aminations | Oct 4, 2018 | Issued |
Array
(
[id] => 15977877
[patent_doc_number] => 10669246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 16/148265
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31093
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148265 | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | Sep 30, 2018 | Issued |
Array
(
[id] => 18216395
[patent_doc_number] => 11591317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Organic molecules for use in optoelectronic devices
[patent_app_type] => utility
[patent_app_number] => 16/755314
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 10809
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 849
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755314 | Organic molecules for use in optoelectronic devices | Sep 30, 2018 | Issued |
Array
(
[id] => 13901603
[patent_doc_number] => 20190040006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/148798
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148798 | Selective androgen receptor modulators (SARMs) and uses thereof | Sep 30, 2018 | Issued |
Array
(
[id] => 16176836
[patent_doc_number] => 20200223804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => CRYSTAL
[patent_app_type] => utility
[patent_app_number] => 16/650390
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650390 | Crystalline substituted pyrazines as PGI2 receptor agonists | Sep 26, 2018 | Issued |
Array
(
[id] => 17680955
[patent_doc_number] => 11365194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Analgesic drug using PAC1 receptor antagonistic drug
[patent_app_type] => utility
[patent_app_number] => 16/650133
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9989
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650133 | Analgesic drug using PAC1 receptor antagonistic drug | Sep 26, 2018 | Issued |
Array
(
[id] => 13826371
[patent_doc_number] => 20190016670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => TRIFLUOROMETHOXYLATION OF ARENES VIA INTRAMOLECULAR TRIFLUOROMETHOXY GROUP MIGRATION
[patent_app_type] => utility
[patent_app_number] => 16/133297
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133297 | Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration | Sep 16, 2018 | Issued |
Array
(
[id] => 17587641
[patent_doc_number] => 11325895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Crystals of tetrahydronaphthyl urea derivative
[patent_app_type] => utility
[patent_app_number] => 16/647223
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 18492
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647223 | Crystals of tetrahydronaphthyl urea derivative | Sep 12, 2018 | Issued |
Array
(
[id] => 15383705
[patent_doc_number] => 10533024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Methods for synthesizing metal mesoporphyrins
[patent_app_type] => utility
[patent_app_number] => 16/125190
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8863
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125190 | Methods for synthesizing metal mesoporphyrins | Sep 6, 2018 | Issued |
Array
(
[id] => 17800110
[patent_doc_number] => 11414390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Cycloolefin substituted heteroaromatic compounds and their use
[patent_app_type] => utility
[patent_app_number] => 16/645329
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 29960
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645329 | Cycloolefin substituted heteroaromatic compounds and their use | Sep 6, 2018 | Issued |
Array
(
[id] => 17800110
[patent_doc_number] => 11414390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Cycloolefin substituted heteroaromatic compounds and their use
[patent_app_type] => utility
[patent_app_number] => 16/645329
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 29960
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645329 | Cycloolefin substituted heteroaromatic compounds and their use | Sep 6, 2018 | Issued |
Array
(
[id] => 15784853
[patent_doc_number] => 10626133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Electrochromic compound, electrochromic composition, and display element
[patent_app_type] => utility
[patent_app_number] => 16/122452
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 9346
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122452 | Electrochromic compound, electrochromic composition, and display element | Sep 4, 2018 | Issued |
Array
(
[id] => 18187505
[patent_doc_number] => 11578074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application
[patent_app_type] => utility
[patent_app_number] => 16/643196
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38478
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 484
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643196 | Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application | Aug 30, 2018 | Issued |
Array
(
[id] => 16673022
[patent_doc_number] => 20210061785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => IMIDAZOLIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/644746
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644746 | Imidazolidine compounds | Aug 30, 2018 | Issued |
Array
(
[id] => 16190727
[patent_doc_number] => 20200231576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => VINYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/643805
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643805 | Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors | Aug 30, 2018 | Issued |
Array
(
[id] => 13774627
[patent_doc_number] => 20190000852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/116418
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116418 | Compounds and compositions for the treatment of parasitic diseases | Aug 28, 2018 | Issued |